Anti-SCUB3/ SCUBE3/ CEGF3 monoclonal antibody

Anti-SCUB3/ SCUBE3/ CEGF3 antibody for FACS & in-vivo assay

Target products collectionGo to SCUBE3/SCUBE3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2319-Ab-1/ GM-Tg-hg-MP2319-Ab-2Anti-Human SCUBE3 monoclonal antibodyHuman
GM-Tg-rg-MP2319-Ab-1/ GM-Tg-rg-MP2319-Ab-2Anti-Rat SCUBE3 monoclonal antibodyRat
GM-Tg-mg-MP2319-Ab-1/ GM-Tg-mg-MP2319-Ab-2Anti-Mouse SCUBE3 monoclonal antibodyMouse
GM-Tg-cynog-MP2319-Ab-1/ GM-Tg-cynog-MP2319-Ab-2Anti-Cynomolgus/ Rhesus macaque SCUBE3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2319-Ab-1/ GM-Tg-felg-MP2319-Ab-2Anti-Feline SCUBE3 monoclonal antibodyFeline
GM-Tg-cang-MP2319-Ab-1/ GM-Tg-cang-MP2319-Ab-2Anti-Canine SCUBE3 monoclonal antibodyCanine
GM-Tg-bovg-MP2319-Ab-1/ GM-Tg-bovg-MP2319-Ab-2Anti-Bovine SCUBE3 monoclonal antibodyBovine
GM-Tg-equg-MP2319-Ab-1/ GM-Tg-equg-MP2319-Ab-2Anti-Equine SCUBE3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2319-Ab-1/ GM-Tg-hg-MP2319-Ab-2; GM-Tg-rg-MP2319-Ab-1/ GM-Tg-rg-MP2319-Ab-2;
GM-Tg-mg-MP2319-Ab-1/ GM-Tg-mg-MP2319-Ab-2; GM-Tg-cynog-MP2319-Ab-1/ GM-Tg-cynog-MP2319-Ab-2;
GM-Tg-felg-MP2319-Ab-1/ GM-Tg-felg-MP2319-Ab-2; GM-Tg-cang-MP2319-Ab-1/ GM-Tg-cang-MP2319-Ab-2;
GM-Tg-bovg-MP2319-Ab-1/ GM-Tg-bovg-MP2319-Ab-2; GM-Tg-equg-MP2319-Ab-1/ GM-Tg-equg-MP2319-Ab-2
Products NameAnti-SCUBE3 monoclonal antibody
Formatmab
Target NameSCUBE3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SCUBE3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SCUB3/ SCUBE3/ CEGF3 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2319
    Target NameSCUBE3
    Gene ID222663,268935,294297,718726,481753,101097643,100300124,100629959
    Gene Symbol and SynonymsCEGF3,D030038I21Rik,SCUBE3,SSFSC2
    Uniprot AccessionQ8IX30
    Uniprot Entry NameSCUB3_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000146197
    Target ClassificationN/A

    The target: SCUBE3, gene name: SCUBE3, also named as CEGF3. This gene encodes a member of the signal peptide, complement subcomponents C1r/C1s, Uegf, bone morphogenetic protein-1 and epidermal growth factor-like domain containing protein family. Overexpression of this gene in human embryonic kidney cells results in secretion of a glycosylated form of the protein that forms oligomers and tethers to the cell surface. This gene is upregulated in lung cancer tumor tissue compared to healthy tissue and is associated with loss of the epithelial marker E-cadherin and with increased expression of vimentin, a mesenchymal marker. In addition, the protein encoded by this gene is a transforming growth factor beta receptor ligand, and when secreted by cancer cells, it can be cleaved in vitro to release the N-terminal epidermal growth factor-like repeat domain and the C-terminal complement subcomponents C1r/C1s domain. Both the full length protein and C-terminal fragment can bind to the transforming growth factor beta type II receptor to promote the epithelial-mesenchymal transition and tumor angiogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.